• About
  • Board
  • News
  • Sign Up
  • Contact

Visit

VJHemOnc
Logo
  • Home (current)
  • Diseases
    ALL
    AML
    CLL
    Lymphoma
    Multiple Myeloma
    Myeloproliferative Neoplasms
    View all Diseases
  • Topics
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    Transplantation
    View all Topics
  • Conferences
    ASH
    2018
    UKONS
    2018
    ERIC
    2018
    BOPA
    2018
    ESH MM
    2018
    EORTC CLTF
    2018
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

MDS

1:48
Pre-transplant MRD status by NGS as a prognostic tool for AML and MDS
Saar Gill
1:12
Hypomethylating agents for low risk MDS
Eunice Wang
1:32
IDH inhibitors for AML and MDS
Eunice Wang
3:41
Computational methods are the future of biological research
Dominique Bonnet
3:38
A new set of treatment options for low-risk MDS
Esther Oliva
1:44
A worldwide Phase III trial treating AML with pracinostat
Guillermo Garcia-Manero
3:36
Highlights: ASCO 2018 oral abstract presentations
Guillermo Garcia-Manero
0:47
Targeting DNA methylation as a therapeutic target in multiple myeloma
Benjamin Barwick
0:52
Therapeutics targeting splicing in hematological malignancies
Omar Abdel-Wahab
3:55
The molecular mechanisms of epigenetic therapies: LTRs and TINATs
Christoph Plass
1:43
The drugs being used to treat newly diagnosed AML patients
Mark Levis
1:41
The future of AML and MDS diagnosis and treatment
Stéphane de Botton
1:02
Bispecific agents: the future of AML and MDS treatment?
John DiPersio
0:52
HARMONY: a collaboration between 51 partners
Lars Bullinger
5:47
Using computational algorithms to predict the response of MDS patients to hypomethylating agents
Aziz Nazha
2:39
Film-coated tablet deferasirox formulation for thalassemia and myelodysplastic syndromes (MDS)
Ali Taher
  • 1
  • 2
  • Next
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

Please enter your details if you would like to receive the latest Hemonc news and updates

Continue
Video channels
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Acute Promyelocytic Leukemia
  • Amyloidosis
  • Anemia
  • Aplastic Anemia
  • B-Cell Lymphoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • CNS Lymphoma
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use